William Blair Upgrades ResMed (RMD) to Outperform

October 24, 2014 7:09 AM

William Blair upgraded ResMed (NYSE: RMD) from Market Perform to Outperform.

For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.